Thoratec Set To Accept St. Jude Acquisition Offer As Go Shop Period Ends
This article was originally published in Clinica
St. Jude Medical is on track to acquire ventricular assist device-maker Thoratec in the fourth quarter of 2015, now that the "go shop" period specified in the merger agreement has ended.
You may also be interested in...
A media report stating Abbott was readying to buy St. Jude Medical was quickly shot down by the company. The firms do, though, have relatively complementary product portfolios
St. Jude Medical says it will pay $3.4 billion to own ventricular-assist device leader Thoratec, pointing to significant synergies in the heart failure and interventional cardiology markets. The deal would thrust VADs into a diversified cardiology firm for the first time, and it includes a "go-shop" period that leaves an opening for other big device firms to enter competing bids.
Navitor is an upgraded version of Abbott’s Portico TAVR system with a better fabric cuff and large curved aortic “cells” to reduce the risk of injury to the native valve.